敗血症診斷市場：趨勢、機會與競爭分析 [2023-2028]

敗血症診斷市場趨勢與預測

預計到2028年，全球敗血症診斷市場將達到 10 億美元，2023年至2028年年複合成長率為 8.1%。該市場的主要促進因素包括敗血症診斷研究活動的公共和私人資金增加、感染疾病風險上升、敗血症發病率增加以及政府配合措施提高公眾敗血症意識。全球敗血症診斷市場前景廣闊，醫院/診所、病理/標準實驗室和研究所市場蘊含商機。

敗血症診斷市場洞察

• Lucintel 認為，由於人口高齡化、血流感染疾病增加以及臨床醫生擴大採用最簡單、最經濟有效的檢測方法，血液培養基將在預測期內成為最大的細分市場。
• 在這個市場中，醫院和診所是最大的細分市場，因為到醫院就診的罹患患者數量不斷增加，各種疾病導致的死亡人數不斷增加，以及可用於敗血症診斷和治療的各種設備的可得性。
• 由於醫療基礎設施完善、先進診斷解決方案的採用不斷增加以及敗血症和感染疾病罹患率的增加，北美在預測期內仍將是最大的地區。

本報告回答了 11 個關鍵問題：

• Q.1.細分市場中最有前途和高成長的機會為何？
• Q.2.哪個細分市場將以更快的速度成長？理由為何？
• Q.3.哪些地區未來會出現更快的成長？理由為何？
• Q.4.影響市場動態的主要要素有哪些？市場的主要挑戰和業務風險是什麼？
• Q.5.這個市場的商業風險和競爭威脅為何？
• Q.6.這個市場有哪些新趨勢？理由為何？
• Q.7.市場客戶需求有何改變？
• Q.8.該市場有哪些新發展以及哪些公司處於領先地位？
• Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
• Q.10.該市場上的競爭產品有哪些，由於材料或產品替代導致市場佔有率下降的威脅有多大？
• Q.11.過去年度發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章 執行摘要

第2章 全球敗血症診斷市場：市場動態

• 簡介、背景、分類
• 供應鏈
• 產業促進因素與挑戰

第3章 2017-2028年市場趨勢及預測分析

• 宏觀經濟趨勢(2017-2022)與預測(2023-2028)
• 全球敗血症診斷市場趨勢(2017-2022)與預測(2023-2028)
• 依產品的全球敗血症診斷市場
  • 樂器
  • 血培養基
  • 檢測試劑盒和試劑
  • 軟體
• 依技術分類的全球敗血症診斷市場
  • 微生物學
  • 分子診斷
  • 免疫學測試
  • 流式細胞儀
  • 其他
• 依最終用途產業分類的全球敗血症診斷市場
  • 醫院和診所
  • 病理學和參考實驗室
  • 調查機構
  • 其他

第4章 2017-2028年分地區市場趨勢及預測分析

• 全球敗血症診斷市場(依地區)
• 北美敗血症診斷市場
• 歐洲敗血症診斷市場
• 亞太地區敗血症診斷市場
• 其他區域敗血症診斷市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 依產品的全球敗血症診斷市場成長機會
  • 依技術的全球敗血症診斷市場的成長機會
  • 依最終用途行業全球敗血症診斷市場成長機會
  • 依地區分類的全球敗血症診斷市場成長機會
• 全球敗血症診斷市場的新興趨勢
• 戰略分析
  • 新產品開發
  • 擴大全球敗血症診斷市場的產能
  • 全球敗血症診斷市場的合併、收購與合資企業
  • 認證和許可

第7章 主要企業概況

• bioMerieux SA
• Becton, Dickinson & Company
• Thermo Fisher Scientific
• F.Hoffmann-La Roche
• Danaher
• Luminex
• Cepheid
• Bruker Corporation
• Immunexpress
• Koninklijke Philips

Sepsis Diagnostic Market Trends and Forecast

The future of the global sepsis diagnostic market looks promising with opportunities in the hospital & clinic, pathology & reference laboratory, and research institute markets. The global sepsis diagnostic market is expected to reach an estimated $1.0 billion by 2028 with a CAGR of 8.1% from 2023 to 2028. The major drivers for this market are growing public-private funding for sepsis diagnostic research activities, rising risk of infectious diseases, as well as increasing number of sepsis incidences, and government initiatives towards developing sepsis awareness among people.

A more than 150-page report is developed to help in your business decisions.

Sepsis Diagnostic Market by Segment

The study includes trends and forecast for the global sepsis diagnostic market by product, technology, end use industry, and region, as follows:

Sepsis Diagnostic Market by Product [Shipment Analysis by Value from 2017 to 2028]:

• Instruments
• Blood Culture Media
• Assay Kits and Reagents
• Software

Sepsis Diagnostic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry
• Others

Sepsis Diagnostic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

• Hospitals & Clinics
• Pathology & Reference Laboratories
• Research Institutes
• Others

Sepsis Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Sepsis Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, sepsis diagnostic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the sepsis diagnostic companies profiled in this report include:

• bioMerieux SA
• Becton, Dickinson & Company
• Thermo Fisher Scientific
• F. Hoffmann-La Roche
• Danaher
• Luminex
• Cepheid
• Bruker Corporation
• Immunexpress
• Koninklijke Philips

Sepsis Diagnostic Market Insights

• Lucintel forecasts that blood culture media will remain the largest segment over the forecast period due to growing aging population, rising incidences of bloodstream infections and increasing adoption by the clinicians as it considered as the most convenient and economically efficient testing method.
• Within this market, hospitals & clinics will remain the largest segment due to growing number of patients visit in hospitals suffering from sepsis, huge number of fatalities caused by various illnesses, and the availability of various equipment, which can be used for sepsis diagnostic treatments.
• North America will remain the largest region over the forecast period due to existence of a well-established healthcare infrastructure, increasing adoption of advanced diagnostic solutions, and growing incidence of sepsis and infectious diseases in the region

Features of the Sepsis Diagnostic Market

• Market Size Estimates: Sepsis diagnostic market size estimation in terms of value ($B)
• Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
• Segmentation Analysis: Sepsis diagnostic market size by various segments, such as by product, technology, end use industry, and region
• Regional Analysis: Sepsis diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different products, technologies, end use industries, and regions for the sepsis diagnostic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the sepsis diagnostic market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q1. What is the sepsis diagnostic market size?
• Answer: The global sepsis diagnostic market is expected to reach an estimated $1.0 billion by 2028.
• Q2. What is the growth forecast for sepsis diagnostic market?
• Answer: The global sepsis diagnostic market is expected to grow with a CAGR of 8.1% from 2023 to 2028.
• Q3. What are the major drivers influencing the growth of the sepsis diagnostic market?
• Answer: The major drivers for this market are growing public-private funding for sepsis diagnostic research activities, rising risk of infectious diseases, as well as increasing number of sepsis incidences, and government initiatives towards developing sepsis awareness among people.
• Q4. What are the major segments for sepsis diagnostic market?
• Answer: The future of the global sepsis diagnostic market looks promising with opportunities in the hospital & clinic, pathology & reference laboratory, and research institute markets.
• Q5. Who are the key sepsis diagnostic companies?
• Answer: Some of the key sepsis diagnostic companies are as follows:
  • bioMerieux SA
  • Becton, Dickinson & Company
  • Thermo Fisher Scientific
  • F. Hoffmann-La Roche
  • Danaher
  • Luminex
  • Cepheid
  • Bruker Corporation
  • Immunexpress
  • Koninklijke Philips
• Q6. Which sepsis diagnostic segment will be the largest in future?
• Answer:Lucintel forecast that blood culture media will remain the largest segment over the forecast period due to growing aging population, rising incidences of bloodstream infections and increasing adoption by the clinicians as it considered as the most convenient and economically efficient testing method.
• Q7. In sepsis diagnostic market, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to existence of a well-established healthcare infrastructure, increasing adoption of advanced diagnostic solutions, and growing incidence of sepsis and infectious diseases in the region.
• Q8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the global sepsis diagnostic market by product (instruments, blood culture media, assay kits and reagents, and software), technology (microbiology, molecular diagnostics, immunoassays, flow cytometry, and others), end use industry (hospitals & clinics, pathology & reference laboratories, research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Sepsis Diagnostic Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Global Sepsis Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Global Sepsis Diagnostic Market by Product
  • 3.3.1: Instruments
  • 3.3.2: Blood Culture Media
  • 3.3.3: Assay Kits and Reagents
  • 3.3.4: Software
• 3.4: Global Sepsis Diagnostic Market by Technology
  • 3.4.1: Microbiology
  • 3.4.2: Molecular Diagnostics
  • 3.4.3: Immunoassays
  • 3.4.4: Flow Cytometry
  • 3.4.5: Others
• 3.5: Global Sepsis Diagnostic Market by End Use Industry
  • 3.5.1: Hospitals & Clinics
  • 3.5.2: Pathology & Reference Laboratories
  • 3.5.3: Research Institutes
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Global Sepsis Diagnostic Market by Region
• 4.2: North American Sepsis Diagnostic Market
  • 4.2.1: North American Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
  • 4.2.2: North American Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others
• 4.3: European Sepsis Diagnostic Market
  • 4.3.1: European Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
  • 4.3.2: European Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others
• 4.4: APAC Sepsis Diagnostic Market
  • 4.4.1: APAC Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
  • 4.4.2: APAC Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others
• 4.5: ROW Sepsis Diagnostic Market
  • 4.5.1: ROW Sepsis Diagnostic Market by Product: Instruments, Blood Culture Media, Assay Kits and Reagents, and Software
  • 4.5.2: ROW Sepsis Diagnostic Market by End Use Industry: Hospitals & Clinics, Pathology & Reference Laboratories, Research Institutes, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Sepsis Diagnostic Market by Product
  • 6.1.2: Growth Opportunities for the Global Sepsis Diagnostic Market by Technology
  • 6.1.3: Growth Opportunities for the Global Sepsis Diagnostic Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Sepsis Diagnostic Market by Region
• 6.2: Emerging Trends in the Global Sepsis Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Sepsis Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Sepsis Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: bioMerieux SA
• 7.2: Becton, Dickinson & Company
• 7.3: Thermo Fisher Scientific
• 7.4: F. Hoffmann-La Roche
• 7.5: Danaher
• 7.6: Luminex
• 7.7: Cepheid
• 7.8: Bruker Corporation
• 7.9: Immunexpress
• 7.10: Koninklijke Philips